Diagnosis and pharmacological management of Parkinson’s disease



Download the guideline

[arrow] Full guideline [Acrobat logo] (515K)
[arrow] Quick reference guide [Acrobat logo] (228K)
arrow Apple app apple badge small
arrow Android app android badge small
[arrow] Summary of recommendations [Word logo] (247K)
[arrow] Information about Acrobat files


This guideline provides recommendations based on current evidence for best practice in the diagnosis and pharmacological management of Parkinsons Disease.


Guideline No. 113, ISBN 978 1 905813 54 4
January 2010

Patient information

Supporting material

[arrow] Search narrative [Acrobat logo] (22K)
[arrow] Register of Interest
A register of interest is not available for this guideline. In line with the SIGN Document Retention Schedule (24/07/2010), after publication of this guideline, hard copies of declarations of interest were held at the SIGN Executive offices for one year. The declarations of interest were then archived for a further three years before being destroyed along with other guideline related documents. This schedule has now been revised.


Related guidelines


Share with a colleague